Nathalie Chabbert-Buffet

Nathalie Chabbert-Buffet

Auto-generated profile, based on publicly available information

Nathalie Chabbert-Buffet

Department of Obstetrics, Gynecology and Reproductive Medicine Tenon Hospital AP‐HP Sorbonne University Paris France

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GCGeoffroy Canlorbe
Geoffroy Canlorbe
NCNathalie Chabbert-Buffet
Nathalie Chabbert-Buffet
CUCatherine Uzan
Catherine Uzan
(1) Background: although most patients with epithelial ovarian cancer (EOC) undergo radical surgery, patients with early-stage disease, borderline ovarian tumor (BOT) or a non-epithelial tumor could be offered fertility-sparing surgery (FSS) depending on histologic subtypes and prognostic factors. (2) Methods: we conducted a systematic review to assess the safety and fertility outcomes of FSS in the treatment of ovarian cancer. We queried the MEDLINE, PubMed, Cochrane Library, and Cochrane (“Cochrane Reviews”) databases for articles published in English or French between 1985 and 15 January 2021. (3) Results: for patients with BOT, FSS should be offered to young women with a desire to conceive, even if peritoneal implants are discovered at the time of initial surgery. Women with mucinous BOT should undergo initial unilateral salpingo-oophorectomy, whereas cystectomy is an acceptable option for women with serous BOT. Assisted reproductive technology (ART) can be initiated in patients with stage I BOT if infertility persists after surgery. For patients with EOC, FSS should only be considered after staging for women with stage IA grade 1 (and probably 2, or low-grade in the current classification) serous, mucinous or endometrioid tumors. FSS could also be offered to patients with stage IC grade 1 (or low-grade) disease. For women with serous, mucinous or endometrioid high-grade stage IA or low-grade stage IC1 or IC2 EOC, bilateral salpingo-oophorectomy and uterine conservation could be offered to allow pregnancy by egg donation. Finally, FSS has a large role to play in patients with non- epithelial ovarian cancer, and particularly women with malignant ovarian germ cell tumors.

21 July 2022 in The European Journal of Contraception & Reproductive Health Care
Verified
Journal Article
Open access
KGKristina Gemzell-Danielsson
Kristina Gemzell-Danielsson
ACAngelo Cagnacci
Angelo Cagnacci
NCNathalie Chabbert-Buffet
Nathalie Chabbert-Buffet
JDJonathan Douxfils
Jonathan Douxfils
JFJean-Michel Foidart
Jean-Michel Foidart
VTVera Tóth
Vera Tóth
Despite considerable advances in recently developed combined oral contraceptives (COCs), resulting in lower rates of adverse events while maintaining contraceptive efficacy, there is interest in fu...

4 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KKKamila Kolanska
Kamila Kolanska
SBSofiane Bendifallah
Sofiane Bendifallah
GCGeoffroy Canlorbe
Geoffroy Canlorbe
AMArsene Mekinian
Arsene Mekinian
CTCyril Touboul
Cyril Touboul
EDEmile Darai
Emile Darai
The molecular responses to hormonal stimuli in the endometrium are modulated at the transcriptional and post-transcriptional stages. Any imbalance in cellular and molecular endometrial homeostasis may lead to gynecological disorders. MicroRNAs (miRNAs) are involved in a wide variety of physiological mechanisms and their expression patterns in the endometrium are currently attracting a lot of interest. miRNA regulation could be hormone dependent. Conversely, miRNAs could regulate the action of sexual hormones. Modifications to miRNA expression in pathological situations could either be a cause or a result of the existing pathology. The complexity of miRNA actions and the diversity of signaling pathways controlled by numerous miRNAs require rigorous analysis and findings need to be interpreted with caution. Alteration of miRNA expression in women with endometriosis has been reported. Thus, a potential diagnostic test supported by a specific miRNA signature could contribute to early diagnosis and a change in the therapeutic paradigm. Similarly, specific miRNA profile signatures are expected for RIF and endometrial cancer, with direct implications for associated therapies for RIF and adjuvant therapies for endometrial cancer. Advances in targeted therapies based on the regulation of miRNA expression are under evaluation.

18 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MBMarieke G. M. Braem
Marieke G. M. Braem
NON. Charlotte Onland-Moret
N. Charlotte Onland-Moret
Leo SchoutenLeo Schouten
Leo Schouten
RKRoy Kruitwagen
Roy Kruitwagen
ALAnnekatrin Lukanova
Annekatrin Lukanova
PPPetra H. M. Peeters
Petra H. M. Peeters
While the risk of ovarian cancer clearly reduces with each full-term pregnancy, the effect of incomplete pregnancies is unclear. We investigated whether incomplete pregnancies (miscarriages and induced abortions) are associated with risk of epithelial ovarian cancer. This observational study was carried out in female participants of the European Prospective Investigation into Cancer and Nutrition (EPIC). A total of 274,442 women were followed from 1992 until 2010. The baseline questionnaire elicited information on miscarriages and induced abortions, reproductive history, and lifestyle-related factors. During a median follow-up of 11.5 years, 1,035 women were diagnosed with incident epithelial ovarian cancer. Despite the lack of an overall association (ever vs. never), risk of ovarian cancer was higher among women with multiple incomplete pregnancies (HR≥4vs.0: 1.74, 95% CI: 1.20–2.70; number of cases in this category: n = 23). This association was particularly evident for multiple miscarriages (HR≥4vs.0: 1.99, 95% CI: 1.06–3.73; number of cases in this category: n = 10), with no significant association for multiple induced abortions (HR≥4vs.0: 1.46, 95% CI: 0.68–3.14; number of cases in this category: n = 7). Our findings suggest that multiple miscarriages are associated with an increased risk of epithelial ovarian cancer, possibly through a shared cluster of etiological factors or a common underlying pathology. These findings should be interpreted with caution as this is the first study to show this association and given the small number of cases in the highest exposure categories.

9 March 2017 in The European Journal of Contraception & Reproductive Health Care
Verified
Journal Article
Closed access
NCNathalie Chabbert-Buffet
Nathalie Chabbert-Buffet
CJChristian Jamin
Christian Jamin
ILIñaki Lete
Iñaki Lete
PLPaloma Lobo
Paloma Lobo
RNRossella E. Nappi
Rossella E. Nappi
CFChristian Fiala
Christian Fiala
Objectives: Oral hormonal contraception is an effective contraceptive method as long as regular daily intake is maintained. However, a daily routine is a constraint for many women and can lead to missed pills, pill discontinuation and/or unintended pregnancy. This article describes the frequency of inconsistent use, the consequences, the risk factors and the possible solutions. Methods: The article comprises a narrative review of the literature. Results: Forgetting one to three pills per cycle is a frequent problem among 15–51% of users, generally adolescents. The reasons for this are age, inability to establish a routine, pill unavailability, side effects, loss of motivation and lack of involvement in the initial decision to use oral contraceptives. The consequences are ‘escape ovulations’ and, possibly, unintended pregnancy. Solutions are either to use a long-acting method or, for women who prefer to take oral contraceptives, use a continuous or long-cycle regimen to reduce the risks of follicular development and thus the likelihood of ovulation and unintended pregnancy. A progestogen with a long half-life can increase ovarian suppression. Conclusions: For women deciding to use oral contraceptives, a shortened or eliminated hormone-free interval and a progestogen with a long half-life may be an option to reduce the negative consequences of missed oral contraceptive pills.

1 October 2014 in Journal de Gynécologie Obstétrique et Biologie de la Reproduction
Verified
Journal Article
Closed access
HFH. Fernandez
H. Fernandez
NCN. Chabbert-Buffet
N. Chabbert-Buffet
MKMartin KOSKAS
Martin KOSKAS
ANA. Nazac
A. Nazac